Table 1.
Baseline characteristics of the LADA groups. Values are mean±s.d. (range), except duration, which is median.
| All | Intervention group | Control group | P value | |
|---|---|---|---|---|
| Age (years) | 54.1±14.9 (30–80) | 51.0±14.3 (30–75) | 57.8±15.1 (31–80) | NS |
| Gender (men, %) | 51.4 | 45.0 | 58.8 | NS |
| Diabetes duration (months) | 5.0 (1–24) | 6.0 (1.5–24) | 5.0 (1–22) | NS |
| BMI (kg/m2) | 27.8±6.2 (19.4–49.5) | 27.0±6.9 (19.4–49.5) | 28.7±5.3 (22.0–42.2) | NS |
| C-peptide (stimulated, nmol/l) | 1.45±0.83 (0.29–3.4) | 1.2±0.73 (0.29–3.0) | 1.7±0.86 (0.65–3.4) | 0.03 |
| HbAlc (%) | 7.2±1.3 (5.2–10.1) | 7.3±1.3 (5.6–10.1) | 7.0±1.3 (5.2–9.5) | NS |
| Titre GADA (index, ref <0.08) | 0.78±0.43 (0.6–1.6) | 0.78±0.39 (0.06–1.6) | 0.78±0.48 (0.12–1.6) | NS |
| Titre ICA (JDF-U) | 50.2±89 (0.0–449) | 29.4±40.5 | 72.4±118 | NS |
| Hypertension (%) | 39.4 | 41.2 | 37.5 | NS |
| BMI >25 kg/m2 (%) | 42.0 | 43.5 | 37.5 | NS |
| Hypertension+BMI >25 kg/m2 (%) | 32.4 | 29.4 | 37.5 | NS |